269 related articles for article (PubMed ID: 25154499)
21. Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
Karathedath S; Rajamani BM; Musheer Aalam SM; Abraham A; Varatharajan S; Krishnamurthy P; Mathews V; Velayudhan SR; Balasubramanian P
PLoS One; 2017; 12(5):e0177227. PubMed ID: 28505160
[TBL] [Abstract][Full Text] [Related]
22. NrF2/ARE and NF-κB pathway regulation may be the mechanism for lutein inhibition of human breast cancer cell.
Chang J; Zhang Y; Li Y; Lu K; Shen Y; Guo Y; Qi Q; Wang M; Zhang S
Future Oncol; 2018 Apr; 14(8):719-726. PubMed ID: 29336610
[TBL] [Abstract][Full Text] [Related]
23. The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing.
Choi BH; Ryoo IG; Kang HC; Kwak MK
PLoS One; 2014; 9(9):e107158. PubMed ID: 25226504
[TBL] [Abstract][Full Text] [Related]
24. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
25. Lico A Enhances Nrf2-Mediated Defense Mechanisms against t-BHP-Induced Oxidative Stress and Cell Death via Akt and ERK Activation in RAW 264.7 Cells.
Lv H; Ren H; Wang L; Chen W; Ci X
Oxid Med Cell Longev; 2015; 2015():709845. PubMed ID: 26576227
[TBL] [Abstract][Full Text] [Related]
26. The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance.
Choi BH; Kim JM; Kwak MK
Arch Pharm Res; 2021 Mar; 44(3):263-280. PubMed ID: 33754307
[TBL] [Abstract][Full Text] [Related]
27. Identification of a functional antioxidant response element at the HIF1A locus.
Lacher SE; Levings DC; Freeman S; Slattery M
Redox Biol; 2018 Oct; 19():401-411. PubMed ID: 30241031
[TBL] [Abstract][Full Text] [Related]
28. HCV-induced oxidative stress by inhibition of Nrf2 triggers autophagy and favors release of viral particles.
Medvedev R; Ploen D; Spengler C; Elgner F; Ren H; Bunten S; Hildt E
Free Radic Biol Med; 2017 Sep; 110():300-315. PubMed ID: 28673615
[TBL] [Abstract][Full Text] [Related]
29. Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
Liu Y; Lu Y; Celiku O; Li A; Wu Q; Zhou Y; Yang C
J Natl Cancer Inst; 2019 Oct; 111(10):1033-1041. PubMed ID: 30759236
[TBL] [Abstract][Full Text] [Related]
30. Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.
Mukherjee P; Gupta A; Chattopadhyay D; Chatterji U
Sci Rep; 2017 Aug; 7(1):9170. PubMed ID: 28835684
[TBL] [Abstract][Full Text] [Related]
31. The Roles of 4β-Hydroxywithanolide E from Physalis peruviana on the Nrf2-Anti-Oxidant System and the Cell Cycle in Breast Cancer Cells.
Peng CY; You BJ; Lee CL; Wu YC; Lin WH; Lu TL; Chang FC; Lee HZ
Am J Chin Med; 2016; 44(3):617-36. PubMed ID: 27109152
[TBL] [Abstract][Full Text] [Related]
32. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
Ren D; Villeneuve NF; Jiang T; Wu T; Lau A; Toppin HA; Zhang DD
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1433-8. PubMed ID: 21205897
[TBL] [Abstract][Full Text] [Related]
33. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies.
Hu L; Miao W; Loignon M; Kandouz M; Batist G
Cancer Chemother Pharmacol; 2010 Aug; 66(3):467-74. PubMed ID: 19940992
[TBL] [Abstract][Full Text] [Related]
34. Asiatic acid enhances Nrf2 signaling to protect HepG2 cells from oxidative damage through Akt and ERK activation.
Qi Z; Ci X; Huang J; Liu Q; Yu Q; Zhou J; Deng X
Biomed Pharmacother; 2017 Apr; 88():252-259. PubMed ID: 28110191
[TBL] [Abstract][Full Text] [Related]
35. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
36. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
37. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.
Venkatraman G; Benesch MG; Tang X; Dewald J; McMullen TP; Brindley DN
FASEB J; 2015 Mar; 29(3):772-85. PubMed ID: 25398768
[TBL] [Abstract][Full Text] [Related]
38. Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis.
Carlisi D; Buttitta G; Di Fiore R; Scerri C; Drago-Ferrante R; Vento R; Tesoriere G
Cell Death Dis; 2016 Apr; 7(4):e2194. PubMed ID: 27077810
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of Bach1 protects osteoblasts against hydrogen peroxide-induced oxidative damage in vitro by enhancing the activation of Nrf2/ARE signaling.
Tian X; Cong F; Guo H; Fan J; Chao G; Song T
Chem Biol Interact; 2019 Aug; 309():108706. PubMed ID: 31194955
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
